| scholarly article | Q13442814 |
| P2093 | author name string | David O Hodge | |
| Keith H Baratz | |||
| Ryan C Young | |||
| Thomas J Liesegang | |||
| P2860 | cites work | Classification of herpes simplex virus keratitis and anterior uveitis | Q33544574 |
| History of the Rochester Epidemiology Project | Q34374377 | ||
| Herpes zoster ophthalmicus in olmsted county, Minnesota: have systemic antivirals made a difference? | Q34531821 | ||
| Indications for penetrating keratoplasty and associated procedures, 1996-2000. | Q34542633 | ||
| Biology and Molecular Aspects of Herpes Simplex and Varicell-zoster Virus Infections | Q35228586 | ||
| Efficacy of oral antiviral prophylaxis in preventing ocular herpes simplex virus recurrences in patients with and without self-reported atopy | Q36608656 | ||
| Keratitis dendritica. An epidemiological investigation | Q43418006 | ||
| The incidence of herpetic keratitis among population | Q43507708 | ||
| Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial | Q43750159 | ||
| Prevention of herpes simplex virus eye disease: a cost-effectiveness analysis | Q44275559 | ||
| Long-term acyclovir use to prevent recurrent ocular herpes simplex virus infection | Q44684807 | ||
| Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection. The Acyclovir Study Group | Q44951756 | ||
| Incidence of herpes simplex virus keratitis in France | Q45469421 | ||
| Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial | Q45832697 | ||
| Effect of acyclovir on herpetic ocular recurrence using a structural nested model | Q46505684 | ||
| Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982 | Q69674144 | ||
| Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982 | Q69742268 | ||
| Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes | Q70199438 | ||
| Population-based study of herpes zoster and its sequelae | Q72112939 | ||
| Immune responses to varicella-zoster in the aged | Q72922288 | ||
| Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Herpetic Eye Disease Study Group | Q74098387 | ||
| Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group | Q77060539 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 1178-1183 | |
| P577 | publication date | 2010-09-01 | |
| P1433 | published in | JAMA Ophthalmology | Q4787301 |
| P1476 | title | Incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976-2007: the effect of oral antiviral prophylaxis | |
| P478 | volume | 128 |
| Q37646133 | Alopecia following oral acyclovir for the treatment of herpes simplex keratitis |
| Q54264680 | An M2 Rather than a TH2 Response Contributes to Better Protection against Latency Reactivation following Ocular Infection of Naive Mice with a Recombinant Herpes Simplex Virus 1 Expressing Murine Interleukin-4. |
| Q24186663 | Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis |
| Q24235637 | Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis |
| Q39019254 | Challenges of corneal infections |
| Q36055513 | Changes in Corneal Innervation after HSV-1 Latency Established with Different Reactivation Phenotypes |
| Q37360882 | Clinical Features and Prognosis of Herpetic Anterior Uveitis |
| Q91796002 | Concomitant herpes simplex keratitis and autoimmune-associated ulcerative keratitis in rheumatoid arthritis patients |
| Q89866345 | Concomitant herpetic keratitis and acute retinal necrosis: clinical features and outcomes |
| Q26785488 | Congenital Corneal Anesthesia and Neurotrophic Keratitis: Diagnosis and Management |
| Q92351022 | Corneal Sub-Basal Nerve Changes in Patients with Herpetic Keratitis During Acute Phase and after 6 Months |
| Q42174405 | Corneal ulcer? Think beyond only a bacterial etiology. |
| Q28082276 | Current aspects on the management of viral uveitis in immunocompetent individuals |
| Q37940579 | Delayed type hypersensitivity in the pathogenesis of recurrent herpes stromal keratitis |
| Q36227278 | Dendritic Cell Autophagy Contributes to Herpes Simplex Virus-Driven Stromal Keratitis and Immunopathology |
| Q35242893 | Diffusion tensor magnetic resonance imaging of trigeminal nerves in relapsing herpetic keratouveitis |
| Q36460600 | Diversity of microbial species implicated in keratitis: a review |
| Q27026675 | Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications |
| Q58598629 | HSV-1 ICP22 suppresses CD80 expression by murine dendritic cells |
| Q90286933 | Herpes Simplex Virus 1 Replication, Ocular Disease, and Reactivations from Latency Are Restricted Unilaterally after Inoculation of Virus into the Lip |
| Q34297293 | Herpes keratitis |
| Q36483475 | Herpesvirus entry mediator is a serotype specific determinant of pathogenesis in ocular herpes. |
| Q29353568 | Incidence of Alpha-Herpes virus induced ocular disease in Suriname |
| Q37055042 | Increasing Incidence of Herpes Zoster Over a 60-year Period From a Population-based Study |
| Q37551831 | Inhibition of ataxia telangiectasia mutated (ATM) kinase suppresses herpes simplex virus type 1 (HSV-1) keratitis |
| Q46749553 | Investigating the effect of corneal Herpes Simplex Virus-1 infection on Toll-Like Receptor expression in human peripheral blood mononuclear cells |
| Q35061490 | Lytic HSV-1 infection induces the multifunctional transcription factor Early Growth Response-1 (EGR-1) in rabbit corneal cells |
| Q47095036 | New Paradigms for the Study of Ocular Alphaherpesvirus Infections: Insights into the Use of Non-Traditional Host Model Systems. |
| Q37671413 | Nonthermal Dielectric Barrier Discharge (DBD) Plasma Suppresses Herpes Simplex Virus Type 1 (HSV-1) Replication in Corneal Epithelium |
| Q57476625 | Pathogenesis of herpes simplex keratitis: The host cell response and ocular surface sequelae to infection and inflammation |
| Q38475791 | Persistent dilemmas in zoster eye disease |
| Q40608331 | Phenylalanine residues at the carboxyl terminus of the herpes simplex virus 1 UL20 membrane protein regulate cytoplasmic virion envelopment and infectious virus production |
| Q58570929 | R430: A potent inhibitor of DNA and RNA viruses |
| Q40132681 | Seroprevalence of HSV-1 and HSV-2 antibodies in Canadian women screened for enrolment in a herpes simplex virus vaccine trial |
| Q64075239 | The Role of T Cells in Herpes Stromal Keratitis |
| Q38258487 | The epidemiology of herpes simplex virus eye disease in Northern California |
| Q41182012 | The use of human cornea organotypic cultures to study herpes simplex virus type 1 (HSV-1)-induced inflammation |
| Q37841552 | Treatment of viral conjunctivitis with antiviral drugs |
| Q35923962 | Trends in the indications for penetrating keratoplasty in Shandong, 2005-2010. |
| Q98726066 | Update on Herpes simplex keratitis management |
Search more.